カテゴリ： Allied Market Research, 世界, 医療/バイオ

HPV検査＆パップテストのグローバル市場（2021〜2031）：HPV検査、パップテスト、同時検査

■ 英語タイトル：HPV Testing & Pap Test Market By Test Type (HPV test, Pap Test, Co-test), By Application (Cervical Cancer, Vaginal Cancer), By Location of Testing (Hospitals and clinics, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MA056）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MA056
■ 発行日：2022年12月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：208
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥535,500見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥859,500見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,440,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[HPV検査＆パップテストのグローバル市場（2021〜2031）：HPV検査、パップテスト、同時検査]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本調査レポートによると、2021年に3,655.97百万ドルであった世界のHPV検査＆パップテスト市場規模が、2031年までに6,647.36百万ドルに達し、2022年から2031年の間に年平均6.1%で成長すると予測されています。本書は、HPV検査＆パップテストの世界市場について調査し、市場動向や今後の展望をまとめた資料です。イントロダクション、エグゼクティブサマリー、市場概要、検査種類別（HPV検査、パップテスト、同時検査）分析、用途別（子宮頸がん、膣がん）分析、検査場所別（病院・診療所、 診断センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況、企業情報など、以下の構成で掲載しています。本書内には、Arbor vita corporation、Becton, Dickinson and Company、Femasys Inc.、Abbott Laboratories、Thermo Fisher Scientific Inc.、Mylab Discovery Solutions Pvt. Ltd、Seegene Inc、Hologic Inc.、F. Hoffmann-La Roche AG、Qaigen NVなど、主な参入企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のHPV検査＆パップテスト市場規模：検査種類別
- HPV検査の市場規模
- パップテストの市場規模
- 同時検査の市場規模
・世界のHPV検査＆パップテスト市場規模：用途別
- 子宮頸がんにおける市場規模
- 膣がんにおける市場規模
・世界のHPV検査＆パップテスト市場規模：検査場所別
- 病院・診療所における市場規模
- 診断センターにおける市場規模
- その他における市場規模
・世界のHPV検査＆パップテスト市場規模：地域別
- 北米のHPV検査＆パップテスト市場規模
- ヨーロッパのHPV検査＆パップテスト市場規模
- アジア太平洋のHPV検査＆パップテスト市場規模
- 中南米・中東・アフリカのHPV検査＆パップテスト市場規模
・競争状況
・企業情報

HPV検査＆パップテストの世界市場は、2021年に3億6597万ドルと評価され、2022年から2031年まで年平均成長率6.1％で成長して2031年には6億6473万ドルに達すると予測されています。
ヒトパピローマウイルス（HPV）は、約150の関連ウイルスのグループです。これらのウイルスは扁平上皮細胞内で生存することができるため、子宮頸部や膣の細胞に感染し、子宮頸がんや膣がんにつながる子宮頸部細胞の異常を引き起こします。また、進行した子宮頸がんにならないためには、HPV検査、パップテスト、またはその両方を組み合わせた検診が推奨されます。HPV検査は、子宮頸がんの原因となる子宮頸部のヒトパピローマウイルスを検出するための検査です。パップテストは、子宮頸部の細胞が異常か正常かを判定する正確なスクリーニング指標となる塗抹検査です。 パップテストで異常細胞があった人は、子宮頸がんをさらに評価するためにヒトパピローマウイルス検査を受けることをお勧めします。

HPV検査＆パップテスト市場の推進要因は、世界中で子宮頸がん患者が増加していること、子宮頸がん検診プログラムの数が増加していること、早期検診に関する教育が行われていることです。例えば、2020年の世界保健機関（WHO）の報告によると、50万人以上の女性が子宮頸がんに罹患し、その結果約34万2,000人の女性が死亡しています。また、2020年の世界保健総会で承認されたWHOの子宮頸がん撲滅のための世界戦略では、世界の女性の70％が、HPV検査、パップスメア検査、または併用検査などの高性能検査で子宮頸がん検診を定期的に受けることが明記されています。さらに、子宮頸がん患者の増加により、検診プログラムの需要が高まっています。COVID-19パンデミックの発症によって悪化した、十分なサービスを受けていない人口集団や低資源地域における子宮頸がんの持続的な負担は、検診率を維持し、さらに向上させるための積極的な戦略や検診オプションの拡大を必要とし、HPV検査＆パップテスト市場の成長を促進します。
しかし、子宮頸がん検診の規制ガイドラインの変更は、HPV検査＆パップテスト市場の成長を抑制します。また、世界中でヒトパピローマウイルスワクチン接種が可能であることも、市場の成長を阻害する可能性があります。

世界のHPV検査＆パップテスト市場は、検査タイプ、用途、検査場所、地域に区分されます。検査タイプ別では、HPV検査、パップテスト、同時検査に分類されます。用途別では、市場は子宮頸がんと膣がんに分別されます。検査場所別では、市場は病院・クリニック、診断センター、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他アジア太平洋）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他LAMEA）に市場を分けて分析しています。

世界のHPV検査＆パップテスト市場で事業を展開する主な主要企業は、Abbott Laboratories、Arbor Vita Corporation、Becton, Dickinson and Company (BD)、F. Hoffmann-La Roche AG、Femasys、Hologic Inc.、Mylab Discovery Solutions Pvt. Ltd、Qaigen NV、Seegene Inc.、Thermo Fischer Scientific Inc.です。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までのHPV検査＆パップテスト市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、HPV検査＆パップテスト市場の有力な市場機会を特定します。
・市場調査は、主要な促進要因、阻害要因、機会に関する情報とともに提供されます。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
・HPV検査＆パップテスト市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域および世界のHPV検査＆パップテスト市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
検査タイプ別
HPV検査
パップテスト
同時検査

用途別
子宮頸がん
膣がん

検査場所別
病院・クリニック
診断センター
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Arbor vita corporation
Becton, Dickinson and Company
Femasys Inc.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Mylab Discovery Solutions Pvt. Ltd
Seegene Inc
Hologic Inc.
F. Hoffmann-La Roche AG
Qaigen NV

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1. Government initiatives and funding for cervical cancer
3.4.1.2. Increase in prevalence of cervical cancer cases
3.4.1.3. Increase in awareness regarding cervical cancer

3.4.2.Restraints
3.4.2.1. Human papillomavirus vaccination
3.4.2.2. Changes in regulatory guidelines and uncertain reimbursement schemes for cervical cancer

3.4.3.Opportunities
3.4.3.1. Growth opportunities in emerging markets

3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: HPV TESTING & PAP TEST MARKET, BY TEST TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2. HPV test
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Pap Test
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Co-test
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: HPV TESTING & PAP TEST MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2. Cervical Cancer
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Vaginal Cancer
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING
6.1 Overview
6.1.1 Market size and forecast
6.2. Hospitals and clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Diagnostic Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4. Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: HPV TESTING & PAP TEST MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Test Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by Location of Testing
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Test Type
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by Location of Testing
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Test Type
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by Location of Testing
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Test Type
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by Location of Testing
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Test Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by Location of Testing
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Test Type
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by Location of Testing
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Test Type
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by Location of Testing
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Test Type
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by Location of Testing
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Test Type
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by Location of Testing
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Test Type
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by Location of Testing
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Test Type
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by Location of Testing
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Test Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by Location of Testing
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Test Type
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by Location of Testing
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Test Type
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by Location of Testing
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Test Type
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by Location of Testing
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Test Type
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by Location of Testing
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Test Type
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by Location of Testing
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Test Type
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by Location of Testing
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Test Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by Location of Testing
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Test Type
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by Location of Testing
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Test Type
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by Location of Testing
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Test Type
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by Location of Testing
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Test Type
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by Location of Testing
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1 Arbor vita corporation
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2 Becton, Dickinson and Company
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 Femasys Inc.
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 Abbott Laboratories
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5 Thermo Fisher Scientific Inc.
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Mylab Discovery Solutions Pvt. Ltd
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 Seegene Inc
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 Hologic Inc.
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 F. Hoffmann-La Roche AG
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 Qaigen NV
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. HPV TESTING & PAP TEST MARKET FOR HPV TEST, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. HPV TESTING & PAP TEST MARKET FOR PAP TEST, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 4. HPV TESTING & PAP TEST MARKET FOR CO-TEST, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. GLOBAL HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 6. HPV TESTING & PAP TEST MARKET FOR CERVICAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. HPV TESTING & PAP TEST MARKET FOR VAGINAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. GLOBAL HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 9. HPV TESTING & PAP TEST MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. HPV TESTING & PAP TEST MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. HPV TESTING & PAP TEST MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. HPV TESTING & PAP TEST MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 16. NORTH AMERICA HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 17. U.S. HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 18. U.S. HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. U.S. HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 20. CANADA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 21. CANADA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. CANADA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 23. MEXICO HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. MEXICO HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 25. MEXICO HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 26. EUROPE HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. EUROPE HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. EUROPE HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 29. EUROPE HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 30. GERMANY HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 31. GERMANY HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 32. GERMANY HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 33. FRANCE HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. FRANCE HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 35. FRANCE HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 36. UK HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. UK HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 38. UK HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 39. ITALY HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. ITALY HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. ITALY HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 42. SPAIN HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. SPAIN HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 44. SPAIN HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 45. REST OF EUROPE HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. REST OF EUROPE HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 47. REST OF EUROPE HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 48. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 50. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 51. ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 52. JAPAN HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. JAPAN HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 54. JAPAN HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 55. CHINA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. CHINA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 57. CHINA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 58. INDIA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. INDIA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 60. INDIA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 61. AUSTRALIA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. AUSTRALIA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 63. AUSTRALIA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 64. SOUTH KOREA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. SOUTH KOREA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 66. SOUTH KOREA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 67. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 69. REST OF ASIA-PACIFIC HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 70. LAMEA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. LAMEA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 72. LAMEA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 73. LAMEA HPV TESTING & PAP TEST MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 74. BRAZIL HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. BRAZIL HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 76. BRAZIL HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 77. SAUDI ARABIA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. SAUDI ARABIA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 79. SAUDI ARABIA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 80. SOUTH AFRICA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. SOUTH AFRICA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 82. SOUTH AFRICA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 83. REST OF LAMEA HPV TESTING & PAP TEST MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. REST OF LAMEA HPV TESTING & PAP TEST MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 85. REST OF LAMEA HPV TESTING & PAP TEST MARKET, BY LOCATION OF TESTING, 2021-2031 (REVENUE, $MILLION)
TABLE 86. ARBOR VITA CORPORATION: KEY EXECUTIVES
TABLE 87. ARBOR VITA CORPORATION: COMPANY SNAPSHOT
TABLE 88. ARBOR VITA CORPORATION: OPERATING SEGMENTS
TABLE 89. ARBOR VITA CORPORATION: PRODUCT PORTFOLIO
TABLE 90. ARBOR VITA CORPORATION: NET SALES
TABLE 91. ARBOR VITA CORPORATION: KEY STRATERGIES
TABLE 92. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 93. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 94. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 95. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 96. BECTON, DICKINSON AND COMPANY: NET SALES
TABLE 97. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 98. FEMASYS INC.: KEY EXECUTIVES
TABLE 99. FEMASYS INC.: COMPANY SNAPSHOT
TABLE 100. FEMASYS INC.: OPERATING SEGMENTS
TABLE 101. FEMASYS INC.: PRODUCT PORTFOLIO
TABLE 102. FEMASYS INC.: NET SALES
TABLE 103. FEMASYS INC.: KEY STRATERGIES
TABLE 104. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 105. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 106. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 107. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 108. ABBOTT LABORATORIES: NET SALES
TABLE 109. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 110. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 111. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 112. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 113. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 114. THERMO FISHER SCIENTIFIC INC.: NET SALES
TABLE 115. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 116. MYLAB DISCOVERY SOLUTIONS PVT. LTD: KEY EXECUTIVES
TABLE 117. MYLAB DISCOVERY SOLUTIONS PVT. LTD: COMPANY SNAPSHOT
TABLE 118. MYLAB DISCOVERY SOLUTIONS PVT. LTD: OPERATING SEGMENTS
TABLE 119. MYLAB DISCOVERY SOLUTIONS PVT. LTD: PRODUCT PORTFOLIO
TABLE 120. MYLAB DISCOVERY SOLUTIONS PVT. LTD: NET SALES
TABLE 121. MYLAB DISCOVERY SOLUTIONS PVT. LTD: KEY STRATERGIES
TABLE 122. SEEGENE INC: KEY EXECUTIVES
TABLE 123. SEEGENE INC: COMPANY SNAPSHOT
TABLE 124. SEEGENE INC: OPERATING SEGMENTS
TABLE 125. SEEGENE INC: PRODUCT PORTFOLIO
TABLE 126. SEEGENE INC: NET SALES
TABLE 127. SEEGENE INC: KEY STRATERGIES
TABLE 128. HOLOGIC INC.: KEY EXECUTIVES
TABLE 129. HOLOGIC INC.: COMPANY SNAPSHOT
TABLE 130. HOLOGIC INC.: OPERATING SEGMENTS
TABLE 131. HOLOGIC INC.: PRODUCT PORTFOLIO
TABLE 132. HOLOGIC INC.: NET SALES
TABLE 133. HOLOGIC INC.: KEY STRATERGIES
TABLE 134. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
TABLE 135. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
TABLE 136. F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
TABLE 137. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
TABLE 138. F. HOFFMANN-LA ROCHE AG: NET SALES
TABLE 139. F. HOFFMANN-LA ROCHE AG: KEY STRATERGIES
TABLE 140. QAIGEN NV: KEY EXECUTIVES
TABLE 141. QAIGEN NV: COMPANY SNAPSHOT
TABLE 142. QAIGEN NV: OPERATING SEGMENTS
TABLE 143. QAIGEN NV: PRODUCT PORTFOLIO
TABLE 144. QAIGEN NV: NET SALES
TABLE 145. QAIGEN NV: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 子宮頸がん診断のグローバル市場：パップテスト、HPV検査、子宮頸部生検、コルポスコピー、その他
  • 子宮頸がん診断のグローバル市場2023-2030：パップテスト/細胞診検査、HPV検査、コルポスコピー検査、子宮頸部生検
  • 尿路感染症検査のグローバル市場（2021～2031）：尿道炎、膀胱炎、腎盂腎炎
  • 子宮頸がん診断のグローバル市場（2023-2032）：パップスミア検査、HPV検査、生検＆ECC、コルポスコピー検査、その他
  • BNP＆NTproBNPのグローバル市場（2021-2031）：心筋梗塞、うっ血性心不全、急性冠症候群（ACS）、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MA056 )"HPV検査＆パップテストのグローバル市場（2021〜2031）：HPV検査、パップテスト、同時検査" (英文：HPV Testing & Pap Test Market By Test Type (HPV test, Pap Test, Co-test), By Application (Cervical Cancer, Vaginal Cancer), By Location of Testing (Hospitals and clinics, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。